Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
5.52
-0.04 (-0.81%)
Jan 28, 2026, 3:23 PM EST - Market open

Atara Biotherapeutics Revenue

Atara Biotherapeutics had revenue of $3.45M in the quarter ending September 30, 2025, a decrease of -91.41%. This brings the company's revenue in the last twelve months to $151.93M, up 51.27% year-over-year. In the year 2024, Atara Biotherapeutics had annual revenue of $128.94M with 1,404.02% growth.

Revenue (ttm)
$151.93M
Revenue Growth
+51.27%
P/S Ratio
0.43
Revenue / Employee
$3,998,158
Employees
38
Market Cap
39.76M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024128.94M120.37M1,404.02%
Dec 31, 20238.57M-55.00M-86.51%
Dec 31, 202263.57M43.23M212.55%
Dec 31, 202120.34M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Celularity40.58M
Generation Bio Co.15.27M
Apollomics6.93M
Lisata Therapeutics1.07M
RenovoRx928.00K
Exicure500.00K
Revenue Rankings